Phase III Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Trial of Gefitinib versus Placebo in Esophageal Cancer Progressing after Chemotherapy, COG (Cancer Oesophagus Gefitinib)
Ferry, D.R., Dutton, S.J., Mansoor, W., Thompson, J., Harrison, M., Abbas, H., Dahle-Smith, A., Chatterjee, A., Falk, S., Garcia-Alonso, A., Fyfe, D.W., Hubner, R., Gamble, T., Peachey, L., Davoudianfar, M., Pearson, S.R., Julier, P., Jankowski, J., Midgely, R., Petty, R.D.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
577 A phase I dose-escalation study of pemetrexed and docetaxel in patients with locally advanced or metastatic cancer: preliminary results of schedule B
Fyfe, D.W., Vasey, P., Woll, P.J., Smith, I.C., Clark, R., Carmichael, J.
Published in European journal of cancer supplements (01.09.2003)
Published in European journal of cancer supplements (01.09.2003)
Get full text
Journal Article
Phase IB study of methoxymorpholinodoxorubicin (PNU 152243; FCE 23762) administered in a 3 or 4 weekly schedule
de Takats, P.G, Dunlop, D., Kaye, S.B., Fyfe, D.W., Baker, P., Pacciarini, M.A., Valota, O., Kerr, D.J.
Published in European journal of cancer (1990) (01.09.1997)
Published in European journal of cancer (1990) (01.09.1997)
Get full text
Journal Article